SU(4) pure-gauge string tensions

In response to recently renewed interests in SU(N) pure-gauge dynamics with large N, both from M/string duality and from finite-temperature QCD phase structure, we calculate string tensions acting between the fundamental 4, diquark 6 and other color charges in SU(4) pure-gauge theory at temperatures below the deconfining phase change and above the bulk phase transition. Our results suggest 4 and 6 representations have different string tensions, with a ratio of about 1.3. We also found the deconfining phase change is not strong.Comment: LATTICE98(hightemp

Analysis of power-saving techniques over a large multi-use cluster with variable workload

Reduction of power consumption for any computer system is now an important issue, although this should be carried out in a manner that is not detrimental to the users of that computer system. We present a number of policies that can be applied to multi-use clusters where computers are shared between interactive users and high-throughput computing. We evaluate policies by trace-driven simulations to determine the effects on power consumed by the high-throughput workload and impact on high-throughput users. We further evaluate these policies for higher workloads by synthetically generating workloads based around the profiled workload observed through our system. We demonstrate that these policies could save 55% of the currently used energy for our high-throughput jobs over our current cluster policies without affecting the high-throughput users’ experience

Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis

Approximately 30% of patients treated with ipilimumab will develop gastrointestinal toxicity. The immunological drivers that underpin the clinical observations in human tissues are poorly understood. We report here on the immune consequences of ipilimumab treatment in the colorectal mucosa of patients with treatment-related colitis. Using immunohistochemistry, we evaluated the immune infiltrate by CD8+, FoxP3, and granzyme B (GzmB) in colonic biopsies from 20 patients with ipilimumab-related colitis. We assessed 10 cases with normal colon biopsies for comparison. In eight cases (four on steroids only, four on steroids and infliximab), we evaluated two sequential biopsies. We observed that CD8+, FoxP3+, and GzmB T cell counts were significantly higher in patients with ipilimumab-related colitis compared to normal colon (p +/FoxP3 ratio than those treated only with steroids and this correlated with clinical severity. The analysis of repeat samples revealed that resolution of the colitis was associated with a decrease in CD8+ and FoxP3+ cells both in patients treated with steroids and infliximab. Our data suggest that counts of cytotoxic T cells and Tregs in the colonic mucosa from patients with ipilimumab-related colitis correlate with clinical findings and may predict severity and guide management

3D Correlative Imaging of Lithium Ion Concentration in a Vertically Oriented Electrode Microstructure with a Density Gradient

The performance of Li+ ion batteries (LIBs) is hindered by steep Li+ ion concentration gradients in the electrodes. Although thick electrodes (≥300 µm) have the potential for reducing the proportion of inactive components inside LIBs and increasing battery energy density, the Li+ ion concentration gradient problem is exacerbated. Most understanding of Li+ ion diffusion in the electrodes is based on computational modeling because of the low atomic number (Z) of Li. There are few experimental methods to visualize Li+ ion concentration distribution of the electrode within a battery of typical configurations, for example, coin cells with stainless steel casing. Here, for the first time, an interrupted in situ correlative imaging technique is developed, combining novel, full-field X-ray Compton scattering imaging with X-ray computed tomography that allows 3D pixel-by-pixel mapping of both Li+ stoichiometry and electrode microstructure of a LiNi0.8 Mn0.1 Co0.1 O2 cathode to correlate the chemical and physical properties of the electrode inside a working coin cell battery. An electrode microstructure containing vertically oriented pore arrays and a density gradient is fabricated. It is shown how the designed electrode microstructure improves Li+ ion diffusivity, homogenizes Li+ ion concentration through the ultra-thick electrode (1 mm), and improves utilization of electrode active materials

Deconfinement transition and string tensions in SU(4) Yang-Mills Theory

We present results from numerical lattice calculations of SU(4) Yang-Mills theory. This work has two goals: to determine the order of the finite temperature deconfinement transition on an $N_t = 6$ lattice and to study the string tensions between static charges in the irreducible representations of SU(4). Motivated by Pisarski and Tytgat's argument that a second-order SU($\infty$) deconfinement transition would explain some features of the SU(3) and QCD transitions, we confirm older results on a coarser, $N_t = 4$, lattice. We see a clear two-phase coexistence signal, characteristic of a first-order transition, at $8/g^2 = 10.79$ on a $6\times 20^3$ lattice, on which we also compute a latent heat of $\Delta\epsilon\approx 0.6 \epsilon_{SB}$. Computing Polyakov loop correlation functions we calculate the string tension at finite temperature in the confined phase between fundamental charges, $\sigma_1$, between diquark charges, $\sigma_2$, and between adjoint charges $\sigma_4$. We find that $1 < \sigma_2/\sigma_1 < 2$, and our result for the adjoint string tension $\sigma_4$ is consistent with string breaking.Comment: 10 pages with included figures. For version 2: New calculation and discussion of latent heat added; 2 new figures and 1 new table. Typo in abstract corrected for v3. To appear in Physical Review

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.

Background: In this retrospective analysis, we explored the prognostic and predictive value of the systemic immune-inflammation index (SII), based on lymphocyte, neutrophil, and platelet counts, at baseline and changes at week 6 during first-line sunitinib in patients with metastatic renal cell cancer (RCC).Results: Patients were stratified into high SII (? 730) and low SII (&lt; 730) groups. SII was associated with objective response, p &lt; 0.0001. The median PFS was 6.3 months (95% CI 5.5–8.9) in patients with SII ? 730 and 18.7 months (95% CI 14.7–22.8) in those with SII &lt; 730, p &lt; 0.0001. The median OS was 43.6 months (95% CI 35.3–52.1) in patients with SII &lt; 730, and 13.5 months (95% CI 9.8–18.5) in those with SII ? 730, p &lt; 0.0001. In multivariate analysis, performance status, IMDC score and SII were able to predict OS (HR = 3.29, HR = 1.71 and HR = 1.79, respectively).Materials and Methods: We included 335 consecutive RCC patients treated with first-line sunitinib. The X-tile 3.6.1 software (Yale University, New Haven, CT) was used for bioinformatic analysis of the data to determine the cutoff value of SII. Progression-free survival (PFS), overall survival (OS) and their 95% confidence interval (95% CI) were estimated by Kaplan-Meier method and compared with logrank test. The impact of SII conversion at week 6 of treatment on PFS and OS was evaluated by Cox regression analyses.Conclusions: The SII and its changes during treatment represent a powerful prognostic indicator of clinical outcome in patients with metastatic RCC

Integrating knowledge on green infrastructure, health and well-being in ageing populations: principles for research and practice

Ageing and urbanisation pose significant challenges for public health and urban planning. Ageing populations are at particular risk from hazards arising from urbanisation processes, some of which are in turn exacerbated by climate change. One approach for mitigating the negative effects of urbanisation on ageing populations is the leveraging of the beneficial effects of urban green infrastructure as a public health intervention in the planning process. We assessed the potential of available theoretical frameworks to provide the context for such leverage. This involved active engagement with academics and practitioners specialising in ageing, green infrastructure and health and well-being through a knowledge-brokering approach. We concluded that an integrated and comprehensive framework on the socio-cultural-ecological determinants of health is lacking. To address this, we present a set of principles for overcoming challenges to knowledge integration when working at the intersection of green infrastructure, ageing, health and well-being. Our findings—and the co-production process used to generate them—have wider significance for trans-disciplinary research into the benefits of the natural environment to human health and well-being as well as other complex and interconnected topics associated with global grand challenges

Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer.

BACKGROUND: To evaluate safety and efficacy of ipilimumab combined with standard first-line chemotherapy for patients with extensive stage SCLC. METHODS: Chemotherapy-naïve extensive stage SCLC patients were treated with carboplatin and etoposide up to six cycles. Ipilimumab 10 mg/kg was given on day 1 of cycles 3-6 and every 12 weeks. Response was assessed by RECIST v1.0 and immune related response criteria (irRC). The primary endpoint was 1-year progression-free survival (PFS) according to RECIST. Secondary endpoints included PFS by irRC (irPFS) and overall survival (OS). Autoantibody serum levels were evaluated and correlated with clinical outcomes. RESULTS: 42 patients were enrolled between September 2011-April 2014, 39 evaluable for safety and 38 for efficacy. 6/38 patients (15.8% [95% CI: 7.4%-30.4%]) were alive and progression-free at 1-year by RECIST. Median PFS was 6.9 months (95%CI: 5.5-7.9). Median irPFS was 7.3 months (95% CI: 5.5-8.8). Median OS was 17.0 months (95% CI: 7.9-24.3). In patients evaluable for response, 21/29 patients (72.4%) achieved an objective response by RECIST and 28/33 (84.8%) by irRC. All patients experienced at least one adverse event; 35/39 (89.7%) patients developed at least one toxicity ≥ Grade 3; in 27 (69.2%) this was related to ipilimumab. Five deaths were reported to be related to ipilimumab. The positivity of an autoimmune profile at baseline was associated with improved outcomes and severe neurological toxicity. CONCLUSION: Ipilimumab in combination with carboplatin and etoposide might benefit a subgroup of patients with advanced SCLC. Autoantibody analysis correlates with treatment benefit and toxicity and warrants further investigation